Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PPD and Charité-Universitätsmedizin Berlin Announce Strategic Collaboration

Published: Saturday, March 01, 2014
Last Updated: Saturday, March 01, 2014
Bookmark and Share
Additional clinical trials to enhance health care delivery.

Pharmaceutical Product Development, LLC (PPD) and the Charité-Universitätsmedizin Berlin have announced a new collaboration between the company and the hospital’s clinical trials management unit (CTMU) to increase the volume of clinical trials conducted in Germany, improve access to commercial clinical research for patients, accelerate the development of new medicines and enhance health care treatment opportunities for German citizens.

The collaboration builds upon the long-standing relationship between PPD and the Charité, one of the largest and most well-respected university hospitals in Europe. With 13,200 employees, the hospital maintains more than 100 clinics and institutes within 17 Charité Centers at its four campuses.

“Germany’s abundance of intellectual and technical resources, coupled with the ongoing advances that have streamlined the clinical research process, make the country extremely attractive for clinical research,” said Roger Newbery, PPD’s vice president of clinical management for Europe, Middle East and Africa. “We welcome the opportunity to strengthen our relationship with a world-class treatment facility that is one of our most experienced and most frequently used clinical research sites globally. Likewise, we are pleased to enhance our support for our clients in expanding their research programs in Germany and around the world.”

PPD will collaborate with the CTMU to shorten study start-up times, maximize the number of patients recruited for clinical trials, generate continued high-quality data and ensure all site staff members are trained as necessary for the conduct of clinical studies.

“By extending our relationship with PPD, our aim is to ensure improved access to novel medicines and advance our mission of securing lasting health improvements for our patients,” said Gerrit Fleige, executive director, finance and administration of the medical faculty of the Charité-Universitätsmedizin Berlin. “As one of the world’s leading contract research organizations, PPD is able to provide us with a wealth of capabilities and services. For instance, this collaboration will further enhance the Charité’s reputation as a global center of excellence for clinical research through a first-class research site and a host of clinical investigators with expertise across a broad spectrum of therapeutic areas."

The agreement includes a wide range of Phase I-IV trials across multiple therapeutic areas. A substantial number of Germany’s 80.5 million citizens have participated in clinical trials, and the country has a significant share of diseases in the key therapeutic areas that are emphasized in clinical research.

With offices in Munich, Karlsruhe and Nuremberg, PPD’s team of more than 400 professionals in Germany offers expertise in biostatistics, clinical management, data management, pharmacovigilance, project management and quality assurance.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PPD Awarded U.S. Army and BARDA Research Contracts
Providing clinical development and vaccine services.
Friday, October 16, 2015
PPD Collaborates with CISYS LifeSciences
Sequence WebEAS helps PPD’s clients reduce effort and cost associated with administering adjudications.
Friday, September 11, 2015
PPD and HealthCore Collaborate
Goal is to establish new quality, cost and speed benchmarks for creating real-world clinical and economic evidence.
Friday, June 19, 2015
PPD Laboratories Opens Central Lab in Shanghai, China
Provides clients with broad range of standardized lab testing services and capabilities.
Friday, April 24, 2015
PPD and SNBL Complete Joint Venture
Joint venture to provide Japanese clinical development services and additional collaborations.
Friday, April 17, 2015
PPD Expands GMP Laboratory in Athlone, Ireland
Analytical testing facility adds cell-based lab capabilities.
Thursday, January 22, 2015
PPD Acquires RCT Logic’s Exclusive License to Patented Clinical Trial Design Technology
Expands PPD’s clinical development capabilities, particularly in neuroscience.
Thursday, September 04, 2014
PPD Acquires Acurian
Strengthens PPD’s comprehensive suite of feasibility, patient recruitment and retention services.
Thursday, August 29, 2013
PPD’s Reputation Ranked Best of all CROs in Global Survey
No. 1 for innovation in improving site relationships and use of technology, data analytics.
Thursday, May 02, 2013
Scientific News
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Zika Vaccine Testing in Humans
The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!